Tag: Roots Analysis

 A detailed assessment of the current market landscape, providing information on drug developer(s) phase of development, type of molecule, type of therapy, type of synlet target, target patient segment, key... Read More

 A detailed assessment of the current market landscape of therapeutics targeting STING Pathway.  A detailed assessment of the current market landscape of various technology platforms that are being actively used... Read More

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have... Read More

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of... Read More

 A detailed review of the overall landscape of fragment-based drug discovery library and service providers.  Elaborate profiles of the companies providing libraries and services for fragment-based drug discovery (shortlisted on... Read More

 A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures.  A comprehensive analysis on the packaging trends of over 230 drug products (including both biologics and... Read More

Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving... Read More

According to experts in this field, the industry is investigating antibodies against novel targets which are expected to drive the market in the coming years. In fact, many service provider... Read More

Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex... Read More

 A detailed assessment of the current market landscape of drug developers engaged in the development of bispecific antibody therapeutics.  A comprehensive analysis of novel technology platforms that are either currently available... Read More